Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. Interleukin 5 Receptor Subunit Alpha Expression as a Potential Biomarker in Patients with Nasal Polyposis

    Biomedicines, Vol. 11, Núm. 7

  2. RNY3 modulates cell proliferation and IL13 mRNA levels in a T lymphocyte model: a possible new epigenetic mechanism of IL-13 regulation

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 1, pp. 59-69

  3. Transcriptomics reveals new regulatory mechanisms involved in benralizumab response

    Allergy: European Journal of Allergy and Clinical Immunology

2022

  1. Identification of Germinal Neurofibromin Hotspots

    Biomedicines, Vol. 10, Núm. 8

2020

  1. Atopy can be an interfering factor in genetic association studies of ß-lactam allergy

    Journal of Investigational Allergology and Clinical Immunology

  2. Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma

    Frontiers in Medicine, Vol. 7

2019

  1. Pharmacogenomics as a Tool for Management of Drug Hypersensitivity Reactions

    Current Treatment Options in Allergy, Vol. 6, Núm. 1

  2. Polymorphisms in CEP68 gene associated with risk of immediate selective reactions to non-steroidal anti-inflammatory drugs

    Pharmacogenomics Journal, Vol. 19, Núm. 2, pp. 191-199

  3. YRNAs overexpression and potential implications in allergy

    World Allergy Organization Journal, Vol. 12, Núm. 8